Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)
Condition: Typhoid Interventions: Biological: Vi-DT (Multi-dose formulation); Biological: Vi-DT (Single dose formulation); Biological: Control Vaccine Sponsors: International Vaccine Institute; SK Bioscience Co., Ltd.; Bill and Melinda Gates Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials